Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 31Other hematologic neoplasm 21Sarcoma 10Plasma cell 8Dermatologic 8Myeloid 5CNS 4Thoracic 3Other neoplasm 2Gynecologic 2Genitourinary 2Classical hematology 2Breast 2Head & Neck 1

Conditions

Ovarian Neoplasms 32Testicular Neoplasms 13Carcinoma, Ovarian Epithelial 9Testicular Germ Cell Tumor 7Teratoma 7Ovarian Germ Cell Cancer 7Sarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Central Nervous System Neoplasms 4Osteosarcoma 3Neoplasms 3Lung Neoplasms 3Fallopian Tube Neoplasms 3Endodermal Sinus Tumor 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Seminoma 2Recurrence 2Optic Nerve Glioma 2Neuroblastoma 2Melanoma 2Medulloblastoma 2Gestational Trophoblastic Disease 2Drug-Related Side Effects and Adverse Reactions 2Desmoplastic Small Round Cell Tumor 2Chondrosarcoma 2Carcinoma, Embryonal 2Brenner Tumor 2Breast Neoplasms 2

Interventions

Carboplatin 19Paclitaxel 17Cisplatin 9Cyclophosphamide 8Gemcitabine 7Bevacizumab 6Topotecan 5pembrolizumab 4olaparib 4liposomal doxorubicin 4durvalumab 4Letrozole 4Interleukin-2 4Drug Therapy 4Doxorubicin 4Albumin-Bound Paclitaxel 4rucaparib 3fludarabine 3chiauranib 3cemiplimab 3camrelizumab 3Therapeutics 3Itraconazole 3Injections 3Hyperthermic Intraperitoneal Chemotherapy 3Everolimus 3pazopanib 2iniparib 2eprenetapopt 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Etoposide × Gynecologic × Clear all
NCT03901118 2021-03-19

Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer

Chipscreen Biosciences, Ltd.

Phase 2 Completed
47 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence

NCT03298074 2017-09-29

Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer

Guangxi Medical University

Phase 2 Unknown
60 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡